Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies

M Kciuk, A Gielecińska, S Mujwar… - Journal of Enzyme …, 2022 - Taylor & Francis
Carbonic anhydrases IX and CAXII (CAIX/CAXII) are transmembrane zinc metalloproteins
that catalyze a very basic but crucial physiological reaction: the conversion of carbon dioxide …

Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain

M Zatovicova, L Jelenska, A Hulikova… - Current …, 2010 - ingentaconnect.com
Carbonic anhydrase IX (CA IX) is a suitable target for various anticancer strategies. It is a
cell surface protein that is present in human tumors, but not in the corresponding normal …

Carbonic anhydrase IX inhibitors in cancer therapy: an update

CT Supuran, JY Winum - Future medicinal chemistry, 2015 - Taylor & Francis
Carbonic anhydrases (CAs; EC 4.2. 1.1) are well known zinc metalloproteins involved in the
catalysis of a very simple but essential physiological reaction: carbon dioxide hydration to …

Cancer drug development of carbonic anhydrase inhibitors beyond the active site

S Singh, CL Lomelino, MY Mboge, SC Frost… - Molecules, 2018 - mdpi.com
Carbonic anhydrases (CAs) catalyze the reversible hydration of carbon dioxide to produce
bicarbonate and a proton. Multiple CA isoforms are implicated in a range of diseases …

Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022

SG Nerella, P Singh, M Arifuddin… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Cancer affects an increasing number of patients each year with an
unacceptable death toll worldwide. A new therapeutic approach to combat tumors consists …

Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII

C Battke, E Kremmer, J Mysliwietz, G Gondi… - Cancer Immunology …, 2011 - Springer
The carbonic anhydrases (CAs) constitute a family of almost ubiquitous enzymes of
significant importance for many physiological and pathological processes. CAs reversely …

Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018)

A Nocentini, CT Supuran - Expert Opinion on Therapeutic Patents, 2018 - Taylor & Francis
Introduction: Human carbonic anhydrases (CA, EC 4.2. 1.1) IX and XII are tumor-associated
proteins, being part of the molecular machinery that tumor cells build as adaptive responses …

Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one

CT Supuran, V Alterio, A Di Fiore… - Medicinal Research …, 2018 - Wiley Online Library
Human carbonic anhydrase (CA) IX is a tumor‐associated protein, since it is scarcely
present in normal tissues, but highly overexpressed in a large number of solid tumors, where …

[HTML][HTML] Recent developments in targeting carbonic anhydrase IX for cancer therapeutics

PC McDonald, JY Winum, CT Supuran, S Dedhar - Oncotarget, 2012 - ncbi.nlm.nih.gov
Carbonic anhydrase IX (CAIX) is a hypoxia-inducible enzyme that is overexpressed by
cancer cells from many tumor types, and is a component of the pH regulatory system …

Targeting tumor-associated carbonic anhydrase IX in cancer therapy

A Thiry, JM Dogne, B Masereel, CT Supuran - Trends in pharmacological …, 2006 - cell.com
Carbonic anhydrase isoform IX (CA IX) is highly overexpressed in many types of cancer. Its
expression, which is regulated by the HIF-1 transcription factor, is strongly induced by …